NCT04544995 2026-01-21Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)GlaxoSmithKlinePhase 1 Terminated47 enrolled 43 charts
NCT06302140 2025-01-20A Mass Balance Study of [14C]-Nanatinostat and Relative Bioavailability Study of Nanatinostat in Patients With Advanced CancersViracta Therapeutics, Inc.Phase 1 Terminated8 enrolled